Results 181 to 190 of about 18,010 (199)

Meropenem/vaborbactam cost effective in Italy

PharmacoEconomics & Outcomes News, 2021
openaire   +1 more source

Immune-globulin/meropenem/vaborbactam

Reactions Weekly, 2020
openaire   +1 more source

Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections

Clinical Infectious Diseases, 2020
Liang Chen, Erin McCreary, Hung T Nguyen   +2 more
exaly  

Avibactam/ceftazidime/colistin/meropenem/vaborbactam

Reactions Weekly, 2020
openaire   +1 more source

Meropenem–Vaborbactam

Reactions Weekly
openaire   +2 more sources

In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2018
Olga Lomovskaya, James Karlowsky, Michael N Dudley   +2 more
exaly  

Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2019
Hung T Nguyen, Yohei Doi, Cornelius Clancy   +2 more
exaly  

Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections

Antimicrobial Agents and Chemotherapy, 2020
Christopher Polk, Danya Roshdy
exaly  

Activity of Meropenem-Vaborbactam against Pseudomonas aeruginosa and Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2019
Mojgan Sabet
exaly  

Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam

Antimicrobial Agents and Chemotherapy, 2018
Jason Roberts, Steven Wallis
exaly